← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Rosuvastatin-Hemicalcium currently has availability issues reported in 2 European registers: Germany, Greece.
Shortage ATC C10AA07 · also listed as: Rosuvastatin-Hemicalcium · data refreshed 11 September 2026
As of 11 September 2026, 2 of the 9 tracked registers list current availability issues for Rosuvastatin-Hemicalcium, covering 11 affected product presentations. The longest-running open report was filed in Germany on 2023-03-06 and has now been open for about 42 months. Where agencies state a cause, manufacturing problems lead with 5 of the 11 stated-cause reports, followed by delivery delays with 4. The furthest expected-resolution date currently on file is 2027-07-31; the earliest is 2026-11-30. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Rosuvastatin-Hemicalcium is coded C10AA07 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage ROSUVASTATIN-ELPEN 10 mg Filmtabletten + 6 more productsROSUVASTATIN-ELPEN 20 mg Filmtabletten ROSUVASTATIN-ELPEN 40 mg Filmtabletten ROSUVASTATIN-ELPEN 5 mg Filmtabletten Rosuvastatin Aristo 10 mg Filmtabletten Rosuvastatin Aristo 20 mg Filmtabletten Rosuvastatin Aristo 5 mg Filmtabletten | 2023-03-06 | 2027-07-31 | Unzureichende Produktionskapazitäten Alternatives: N/A | register ↗ |
| 🇬🇷 Greece | Limited availability Rosuvastatin-Hemicalcium + 3 more productsRosuvastatin-Hemicalcium Rosuvastatin-Hemicalcium Rosuvastatin-Hemicalcium | 2025-12-12 | 2027-03-31 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευάσματα της | register ↗ |
Every individual register entry for Rosuvastatin-Hemicalcium in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | Rosuvastatin-Hemicalcium | Limited availability | 2026-06-15 | 2027-01-31 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇬🇷 GR | Rosuvastatin-Hemicalcium | Limited availability | 2026-04-01 | 2026-11-30 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇬🇷 GR | Rosuvastatin-Hemicalcium | Limited availability | 2026-04-01 | 2027-03-31 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇬🇷 GR | Rosuvastatin-Hemicalcium | Limited availability | 2025-12-12 | 2027-03-31 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇩🇪 DE | Rosuvastatin Aristo 10 mg Filmtabletten | Shortage | 2023-03-24 | 2026-12-31 | Erhöhte Nachfrage |
| 🇩🇪 DE | Rosuvastatin Aristo 20 mg Filmtabletten | Shortage | 2023-03-24 | 2026-12-31 | Erhöhte Nachfrage |
| 🇩🇪 DE | Rosuvastatin Aristo 5 mg Filmtabletten | Shortage | 2023-03-24 | 2026-12-31 | Probleme beim Sonstigen Hersteller |
| 🇩🇪 DE | ROSUVASTATIN-ELPEN 10 mg Filmtabletten | Shortage | 2023-03-06 | 2027-07-31 | Unzureichende Produktionskapazitäten |
| 🇩🇪 DE | ROSUVASTATIN-ELPEN 20 mg Filmtabletten | Shortage | 2023-03-06 | 2027-07-31 | Unzureichende Produktionskapazitäten |
| 🇩🇪 DE | ROSUVASTATIN-ELPEN 40 mg Filmtabletten | Shortage | 2023-03-06 | 2027-07-31 | Unzureichende Produktionskapazitäten |
| 🇩🇪 DE | ROSUVASTATIN-ELPEN 5 mg Filmtabletten | Shortage | 2023-03-06 | 2027-07-31 | Unzureichende Produktionskapazitäten |
Yes. As of 11 September 2026, availability issues are reported in: Germany, Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-30 to 2027-07-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Rosuvastatin-Hemicalcium: BfArM (Germany), EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rosuvastatin-Hemicalcium — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rosuvastatin-hemicalcium/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rosuvastatin-Hemicalcium availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rosuvastatin-hemicalcium/">Rosuvastatin-Hemicalcium shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>